Glucagon-Like Peptide-1 Analog, Liraglutide, Delays Onset of Experimental Autoimmune Encephalitis in Lewis Rats

Introduction: Recent findings indicate that metabolic disturbances are involved in multiple sclerosis (MS) pathology and influence the susceptibility to treatment, directing attention toward anti-diabetic drugs such as metformin and pioglitazone. Liraglutide, a drug of the glucagon-like peptide-1 (G...

Descripción completa

Detalles Bibliográficos
Autores principales: DellaValle, Brian, Brix, Gitte S., Brock, Birgitte, Gejl, Michael, Landau, Anne M., Møller, Arne, Rungby, Jørgen, Larsen, Agnete
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114298/
https://www.ncbi.nlm.nih.gov/pubmed/27917122
http://dx.doi.org/10.3389/fphar.2016.00433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114298/
https://www.ncbi.nlm.nih.gov/pubmed/27917122
http://dx.doi.org/10.3389/fphar.2016.00433

Ejemplares similares